141 related articles for article (PubMed ID: 32203073)
1. The role of advanced glycation end products in vascular aging: which parameter is the most suitable as a biomarker?
Mayer O; Gelžinský J; Seidlerová J; Mateřánková M; Mareš Š; Svobodová V; Trefil L; Cífková R; Filipovský J
J Hum Hypertens; 2021 Mar; 35(3):240-249. PubMed ID: 32203073
[TBL] [Abstract][Full Text] [Related]
2. Soluble receptor for advanced glycation end-products independently influences individual age-dependent increase of arterial stiffness.
Gelžinský J; Mayer O; Seidlerová J; Mateřánková M; Mareš Š; Kordíková V; Trefil L; Cífková R; Filipovský J
Hypertens Res; 2020 Feb; 43(2):111-120. PubMed ID: 31636359
[TBL] [Abstract][Full Text] [Related]
3. Serum biomarkers, skin autofluorescence and other methods. Which parameter better illustrates the relationship between advanced glycation end products and arterial stiffness in the general population?
Gelžinský J; Mayer O; Seidlerová J; Mateřánková M; Mareš Š; Kordíkova V; Trefil L; Cífková R; Filipovský J
Hypertens Res; 2021 May; 44(5):518-527. PubMed ID: 33437026
[TBL] [Abstract][Full Text] [Related]
4. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
5. Circulating Advanced Glycation End Products and Their Soluble Receptors in Relation to All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-analysis of Prospective Observational Studies.
Sharifi-Zahabi E; Sharafabad FH; Abdollahzad H; Malekahmadi M; Rad NB
Adv Nutr; 2021 Dec; 12(6):2157-2171. PubMed ID: 34139010
[TBL] [Abstract][Full Text] [Related]
6. Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.
Scavello F; Tedesco CC; Castiglione S; Maciag A; Sangalli E; Veglia F; Spinetti G; Puca AA; Raucci A
Biomark Med; 2021 Aug; 15(11):785-796. PubMed ID: 34236256
[TBL] [Abstract][Full Text] [Related]
7. Time-varying parameters of glycemic control and glycation in relation to arterial stiffness in patients with type 1 diabetes.
Helleputte S; Calders P; Rodenbach A; Marlier J; Verroken C; De Backer T; Lapauw B
Cardiovasc Diabetol; 2022 Dec; 21(1):277. PubMed ID: 36494687
[TBL] [Abstract][Full Text] [Related]
8. Soluble receptor for advanced glycation end products and increased aortic stiffness in the general population.
Mayer O; Seidlerová J; Filipovský J; Vágovičová P; Wohlfahrt P; Cífková R; Windrichová J; Topolčan O
Hypertens Res; 2016 Apr; 39(4):266-71. PubMed ID: 26631850
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
10. Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension.
Gryszczyńska B; Budzyń M; Begier-Krasińska B; Osińska A; Boruczkowski M; Kaczmarek M; Bukowska A; Iskra M; Kasprzak MP
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412635
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study.
Sabbatinelli J; Castiglione S; Macrì F; Giuliani A; Ramini D; Vinci MC; Tortato E; Bonfigli AR; Olivieri F; Raucci A
Cardiovasc Diabetol; 2022 Jun; 21(1):95. PubMed ID: 35668468
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
[TBL] [Abstract][Full Text] [Related]
13. Association of plasma advanced glycation end-products and their soluble receptor with type 2 diabetes among Chinese adults.
Chen L; Wang Q; Lv Y; Xu W; Jiang G; Li Y; Luo P; He R; Liu L
Diabetes Metab Res Rev; 2024 Feb; 40(2):e3735. PubMed ID: 37817474
[TBL] [Abstract][Full Text] [Related]
14. Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients.
Assiri AMA; Kamel HFM; ALrefai AA
Med Sci (Basel); 2018 May; 6(2):. PubMed ID: 29789493
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products and their ratio to soluble receptor are associated with limitations in physical functioning only in women: results from the CARLA cohort.
Ebert H; Lacruz ME; Kluttig A; Simm A; Greiser KH; Tiller D; Kartschmit N; Mikolajczyk R
BMC Geriatr; 2019 Nov; 19(1):299. PubMed ID: 31684879
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study.
Bijnen M; van Greevenbroek MMJ; van der Kallen CJH; Scheijen JL; van de Waarenburg MPH; Stehouwer CDA; Wouters K; Schalkwijk CG
J Diabetes Res; 2019; 2019():6289831. PubMed ID: 31218233
[TBL] [Abstract][Full Text] [Related]
17. Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis.
Machahua C; Montes-Worboys A; Planas-Cerezales L; Buendia-Flores R; Molina-Molina M; Vicens-Zygmunt V
Respir Res; 2018 Nov; 19(1):215. PubMed ID: 30409203
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of advanced glycation end products in skin and increased vascular ageing in the general population: the Malmö Offspring Study.
Jujic A; Engström G; Nilsson PM; Johansson M
J Hypertens; 2024 Mar; 42(3):530-537. PubMed ID: 38088420
[TBL] [Abstract][Full Text] [Related]
19. Association between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study.
Ebert H; Lacruz ME; Kluttig A; Simm A; Greiser KH; Tiller D; Kartschmit N; Mikolajczyk R
Exp Gerontol; 2020 Mar; 131():110815. PubMed ID: 31857132
[TBL] [Abstract][Full Text] [Related]
20. Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients.
Yoon SJ; Park S; Park C; Chang W; Cho DK; Ko YG; Choi D; Kwon HM; Jang Y; Chung N
Coron Artery Dis; 2012 Mar; 23(2):85-90. PubMed ID: 22198512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
